C34
Conditions
Interventions
Group 1: Patients with histologically confirmed involvement of mediastinal lymph nodes (pN2) of a NSCLS, who qualify for an optional adjuvant radiation of the primary tumor region and the involved ly
Sponsors
Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - age >= 18 years, - pN2 after surgery of the primary tumor and systematic mediastinal lymphadenectomy - with histologically confirmed NSCLC
Exclusion criteria
Exclusion criteria: - R1-status after surgery, because then radiation is indicated in any case - distant metastases - pN1 or pN3
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival (retrospective evaluation) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Loco-regional relapse-free survival: prognostic relevance of the radiation therapy, time interval until progress/relapse after end of radiation therapy or surgery 2) Survival without distant metastases 3) Therapy-associated toxicity. Acute and long-term implications of the radiation therapy (like radioodermatitis, dysphagia, hemotoxicity, radiopneumonitis/-fibrosis) (retrospective evaluation) | — |
Countries
Germany
Contacts
Public ContactUrsula Nestle
Klinik für Strahlenheilkunde
Outcome results
None listed